06.09.2018 Summa Equity Acquires Finnish Antibody Manufacturer HyTest
Summa Equity will become majority shareholder of the Finnish company HyTest, producer of antibodies and antigens for the diagnostic industry.
We Are HyTest
Product Catalog 2018
CPV Antigen
Troponin I Booklet
Antibody development and production since 1994
At HyTest, we manufacture monoclonal antibodies and antigens that are mainly used as key components of laboratory tests. Our company is one of the most important raw material suppliers for the IVD industry.
We provide products in several clinical areas including cardiac markers, infectious diseases, metabolic syndrome and veterinary diagnostics. Our company has become an international market leading raw material supplier for troponin I assays in cardiovascular diseases diagnostics and influenza-virus detection reagents in infectious diseases diagnostics.
Continuous investments in R&D and close collaboration with the scientific community help us to understand the needs of our customers. That is why most of the major diagnostic companies rely on our ability to supply the best reagents in world. Together. Today and Tomorrow.
Let's connect
News
30.08.2018 HyTest Revenue Growth Fueled by Sales in China
During the first half of the year, HyTest’s consolidated revenue grew to 14.4 million euros.
29.08.2018 Podcast: cTnI and its Proteolytic Fragments in Blood
Our latest article on cardiac troponin I was recently published in Clinical Chemistry. Now you can listen...